CIK 1940272
ADAR1 Capital Management, LLC
Institutional 13F holdings & portfolio
Holdings
512
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 51–100 of 512
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| CDTX | CIDARA THERAPEUTICS INC | 60K | $1M+ | SH |
| IVA | INVENTIVA SA | 2.7M | $1M+ | SH |
| IVA | INVENTIVA SA | 2.7M | $1M+ | SH |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 171K | $1M+ | SH |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 171K | $1M+ | SH |
| BIL | SPDR SERIES TRUST | 136K | $1M+ | SH |
| BIL | SPDR SERIES TRUST | 136K | $1M+ | SH |
| REPL | REPLIMUNE GROUP INC | 1.2M | $1M+ | SH |
| REPL | REPLIMUNE GROUP INC | 1.2M | $1M+ | SH |
| IONS | IONIS PHARMACEUTICALS INC | 147K | $1M+ | SH |
| IONS | IONIS PHARMACEUTICALS INC | 147K | $1M+ | SH |
| RVMD | REVOLUTION MEDICINES INC | 145K | $1M+ | SH |
| RVMD | REVOLUTION MEDICINES INC | 145K | $1M+ | SH |
| AMLX | AMYLYX PHARMACEUTICALS INC | 890K | $1M+ | SH |
| AMLX | AMYLYX PHARMACEUTICALS INC | 890K | $1M+ | SH |
| CGON | CG ONCOLOGY INC | 258K | $1M+ | SH |
| CGON | CG ONCOLOGY INC | 258K | $1M+ | SH |
| TFX | TELEFLEX INCORPORATED | 81K | $1M+ | SH |
| TFX | TELEFLEX INCORPORATED | 81K | $1M+ | SH |
| IVVD | INVIVYD INC | 3.9M | $1M+ | SH |
| IVVD | INVIVYD INC | 3.9M | $1M+ | SH |
| REGN | REGENERON PHARMACEUTICALS | 12K | $1M+ | SH |
| REGN | REGENERON PHARMACEUTICALS | 12K | $1M+ | SH |
| XENE | XENON PHARMACEUTICALS INC | 204K | $1M+ | SH |
| XENE | XENON PHARMACEUTICALS INC | 204K | $1M+ | SH |
| EQ | EQUILLIUM INC | 5.6M | $1M+ | SH |
| EQ | EQUILLIUM INC | 5.6M | $1M+ | SH |
| SVRA | SAVARA INC | 1.4M | $1M+ | SH |
| SVRA | SAVARA INC | 1.4M | $1M+ | SH |
| MAZE | MAZE THERAPEUTICS INC | 180K | $1M+ | SH |
| MAZE | MAZE THERAPEUTICS INC | 180K | $1M+ | SH |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 236K | $1M+ | SH |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 236K | $1M+ | SH |
| CBIO | CRESCENT BIOPHARMA INC. | 606K | $1M+ | SH |
| CBIO | CRESCENT BIOPHARMA INC. | 606K | $1M+ | SH |
| OVID | OVID THERAPEUTICS INC | 4.3M | $1M+ | SH |
| OVID | OVID THERAPEUTICS INC | 4.3M | $1M+ | SH |
| IWM | ISHARES TR | 28K | $1M+ | SH (Put) |
| IWM | ISHARES TR | 28K | $1M+ | SH (Put) |
| BLTE | BELITE BIO INC | 40K | $1M+ | SH |
| BLTE | BELITE BIO INC | 40K | $1M+ | SH |
| VRTX | VERTEX PHARMACEUTICALS INC | 14K | $1M+ | SH |
| VRTX | VERTEX PHARMACEUTICALS INC | 14K | $1M+ | SH |
| BHF | BRIGHTHOUSE FINL INC | 96K | $1M+ | SH |
| BHF | BRIGHTHOUSE FINL INC | 96K | $1M+ | SH |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 1.2M | $1M+ | SH |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 1.2M | $1M+ | SH |
| AAM | AA MISSION ACQUISITION CORP | 578K | $1M+ | SH |
| AAM | AA MISSION ACQUISITION CORP | 578K | $1M+ | SH |
| TARA | PROTARA THERAPEUTICS INC | 1.1M | $1M+ | SH |